
Charan Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.79 M
- Company Age 26 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.44 Cr
- Satisfied Charges ₹ 6.00 M
- Revenue Growth 3.51%
- Profit Growth 433.64%
- Ebitda -17.09%
- Net Worth 114.07%
- Total Assets 61.01%
About Charan Laboratories
Charan Laboratories Private Limited (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 June 1998 and has a history of 26 years and eight months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.79 M.
The company currently has active open charges totaling ₹1.44 Cr. The company has closed loans amounting to ₹6.00 M, as per Ministry of Corporate Affairs (MCA) records.
Khushboo Bansal, Rishabh Bansal, and Vipin Bansal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL1998PTC094631
- Company No.
094631
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jun 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Charan Laboratories Private Limited offer?
Charan Laboratories Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Anti Ulcer Drugs, Nutraceuticals & Dietary Supplements, Mineral Supplement, Antispasmodic Drugs, Anti Infective Drugs & Medicines, Antibacterial Drugs, Digestive Drugs, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics.
Who are the key members and board of directors at Charan Laboratories?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Khushboo Bansal ![]() | Director | 10-Mar-2022 | Current |
Rishabh Bansal ![]() | Director | 01-Jul-2015 | Current |
Vipin Bansal ![]() | Director | 23-Jun-1998 | Current |
Financial Performance of Charan Laboratories.
Charan Laboratories Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.51% increase. The company also saw a substantial improvement in profitability, with a 433.64% increase in profit. The company's net worth Soared by an impressive increase of 114.07%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Charan Laboratories?
In 2022, Charan Laboratories had a public holding of 0.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Srv Pharma Private Limited
Rishabh Bansal and Vipin Bansal are mutual person
Charges (Loans)
₹14.44 M
₹6.00 M
Charges Breakdown by Lending Institutions
- Others : 1.30 Cr
- Hdfc Bank Limited : 0.12 Cr
- Bank Of Baroda : 0.02 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
18 Apr 2024 | Hdfc Bank Limited | ₹1.20 M | Open |
30 Mar 2024 | Others | ₹1.25 Cr | Open |
28 Dec 2016 | Others | ₹0.54 M | Open |
20 Dec 2000 | Bank Of Baroda | ₹0.20 M | Open |
07 Mar 2017 | Others | ₹5.00 M | Satisfied |
How Many Employees Work at Charan Laboratories?
Charan Laboratories has a workforce of 2 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Charan Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Charan Laboratories's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.